| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Acute Lung Injury | 5 | 2019 | 904 | 1.37 | Why? |
| Th17 Cells | 2 | 2019 | 657 | 1.02 | Why? |
| T-Lymphocytes, Regulatory | 2 | 2019 | 698 | 0.95 | Why? |
| Forkhead Box Protein M1 | 1 | 2019 | 4 | 0.80 | Why? |
| Glutaredoxins | 1 | 2019 | 15 | 0.80 | Why? |
| Interleukin-1alpha | 1 | 2019 | 42 | 0.77 | Why? |
| Aspergillus fumigatus | 2 | 2017 | 239 | 0.72 | Why? |
| Osteopontin | 1 | 2019 | 96 | 0.71 | Why? |
| Lung Neoplasms | 8 | 2019 | 3228 | 0.70 | Why? |
| Pulmonary Gas Exchange | 1 | 2020 | 414 | 0.69 | Why? |
| Aquaporin 1 | 1 | 2017 | 18 | 0.68 | Why? |
| MAP Kinase Signaling System | 1 | 2019 | 360 | 0.62 | Why? |
| Respiratory Mechanics | 1 | 2020 | 585 | 0.62 | Why? |
| Carcinoma, Non-Small-Cell Lung | 4 | 2019 | 896 | 0.61 | Why? |
| Lung | 14 | 2020 | 31049 | 0.59 | Why? |
| Pulmonary Aspergillosis | 2 | 2017 | 408 | 0.59 | Why? |
| Drug Resistance, Neoplasm | 5 | 2019 | 447 | 0.59 | Why? |
| Acinetobacter Infections | 1 | 2018 | 273 | 0.56 | Why? |
| Pneumonia | 3 | 2019 | 5652 | 0.55 | Why? |
| Acinetobacter baumannii | 1 | 2018 | 378 | 0.55 | Why? |
| Interleukin-1beta | 2 | 2019 | 992 | 0.54 | Why? |
| RNA | 2 | 2019 | 1278 | 0.54 | Why? |
| Particulate Matter | 4 | 2019 | 3249 | 0.53 | Why? |
| Respiration Disorders | 1 | 2019 | 526 | 0.49 | Why? |
| Respiratory Mucosa | 3 | 2018 | 1522 | 0.47 | Why? |
| Disseminated Intravascular Coagulation | 1 | 2020 | 994 | 0.45 | Why? |
| Community-Acquired Infections | 3 | 2019 | 2328 | 0.42 | Why? |
| Bronchoscopy | 2 | 2017 | 991 | 0.41 | Why? |
| Drugs, Chinese Herbal | 3 | 2021 | 2760 | 0.40 | Why? |
| Pneumonia, Ventilator-Associated | 1 | 2018 | 861 | 0.40 | Why? |
| Protein Kinase Inhibitors | 2 | 2019 | 1585 | 0.39 | Why? |
| Zinc | 1 | 2017 | 817 | 0.39 | Why? |
| Lipopolysaccharides | 3 | 2019 | 848 | 0.39 | Why? |
| Sputum | 1 | 2017 | 1720 | 0.38 | Why? |
| Early Diagnosis | 1 | 2017 | 2443 | 0.37 | Why? |
| ErbB Receptors | 3 | 2019 | 320 | 0.35 | Why? |
| Bacteremia | 1 | 2018 | 1372 | 0.32 | Why? |
| Pulmonary Disease, Chronic Obstructive | 6 | 2018 | 3832 | 0.30 | Why? |
| Computer Simulation | 1 | 2020 | 4982 | 0.29 | Why? |
| Intensive Care Units | 3 | 2020 | 29594 | 0.27 | Why? |
| Mice | 11 | 2019 | 21357 | 0.26 | Why? |
| Chlorides | 1 | 2003 | 82 | 0.26 | Why? |
| Mice, Inbred C57BL | 6 | 2019 | 5542 | 0.25 | Why? |
| Models, Biological | 1 | 2020 | 4907 | 0.25 | Why? |
| Adenocarcinoma | 3 | 2019 | 651 | 0.24 | Why? |
| Sodium | 1 | 2003 | 309 | 0.22 | Why? |
| Mice, Nude | 2 | 2019 | 340 | 0.22 | Why? |
| China | 15 | 2020 | 50654 | 0.22 | Why? |
| Hospital Mortality | 4 | 2021 | 22087 | 0.21 | Why? |
| Air Pressure | 1 | 2020 | 119 | 0.21 | Why? |
| Cell Proliferation | 5 | 2019 | 1973 | 0.21 | Why? |
| Quinazolines | 2 | 2019 | 126 | 0.21 | Why? |
| Glycerol Kinase | 1 | 2019 | 1 | 0.20 | Why? |
| Forced Expiratory Volume | 3 | 2018 | 632 | 0.20 | Why? |
| Stearoyl-CoA Desaturase | 1 | 2019 | 13 | 0.20 | Why? |
| Sterol Regulatory Element Binding Protein 1 | 1 | 2019 | 17 | 0.20 | Why? |
| DNA, Neoplasm | 1 | 2019 | 56 | 0.20 | Why? |
| Peroxiredoxin VI | 1 | 2019 | 17 | 0.20 | Why? |
| Critical Illness | 2 | 2020 | 17281 | 0.20 | Why? |
| Mice, Inbred C3H | 1 | 2019 | 102 | 0.20 | Why? |
| Animals | 16 | 2019 | 78931 | 0.19 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2020 | 6166 | 0.19 | Why? |
| Inhibitor of Apoptosis Proteins | 1 | 2018 | 21 | 0.19 | Why? |
| Adrenal Cortex Hormones | 3 | 2021 | 6537 | 0.19 | Why? |
| Pemetrexed | 1 | 2018 | 32 | 0.18 | Why? |
| Cell Count | 1 | 2019 | 228 | 0.18 | Why? |
| Neoplasms, Experimental | 1 | 2018 | 67 | 0.18 | Why? |
| Carcinoma, Large Cell | 1 | 2017 | 13 | 0.18 | Why? |
| RNA Splicing | 1 | 2019 | 119 | 0.18 | Why? |
| Receptors, Vitronectin | 1 | 2017 | 4 | 0.18 | Why? |
| Cellular Senescence | 2 | 2018 | 326 | 0.18 | Why? |
| Asthma | 1 | 2017 | 4383 | 0.17 | Why? |
| Cell Line, Tumor | 4 | 2019 | 3608 | 0.17 | Why? |
| Signal Transduction | 3 | 2019 | 7207 | 0.17 | Why? |
| Interleukin-1 Receptor-Associated Kinases | 1 | 2017 | 56 | 0.17 | Why? |
| Interleukin-2 Receptor alpha Subunit | 1 | 2018 | 234 | 0.17 | Why? |
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2017 | 71 | 0.17 | Why? |
| Reference Values | 1 | 2020 | 795 | 0.17 | Why? |
| Therapy, Computer-Assisted | 1 | 2017 | 39 | 0.17 | Why? |
| Double-Blind Method | 2 | 2019 | 5988 | 0.16 | Why? |
| Lymphocyte Depletion | 1 | 2018 | 293 | 0.16 | Why? |
| Expectorants | 1 | 2017 | 95 | 0.16 | Why? |
| Mucociliary Clearance | 1 | 2017 | 72 | 0.16 | Why? |
| Water-Electrolyte Balance | 1 | 2017 | 136 | 0.16 | Why? |
| Antimicrobial Cationic Peptides | 1 | 2018 | 159 | 0.16 | Why? |
| Pulmonologists | 1 | 2017 | 98 | 0.16 | Why? |
| Oseltamivir | 1 | 2020 | 583 | 0.16 | Why? |
| Transforming Growth Factor beta | 1 | 2018 | 363 | 0.15 | Why? |
| Cisplatin | 1 | 2017 | 209 | 0.15 | Why? |
| Goblet Cells | 1 | 2017 | 181 | 0.15 | Why? |
| Male | 28 | 2021 | 367725 | 0.15 | Why? |
| Biological Transport | 1 | 2017 | 290 | 0.15 | Why? |
| Hypercapnia | 1 | 2017 | 172 | 0.15 | Why? |
| Protein Isoforms | 1 | 2017 | 347 | 0.15 | Why? |
| Chemical and Drug Induced Liver Injury | 1 | 2020 | 451 | 0.15 | Why? |
| Proto-Oncogene Proteins c-akt | 1 | 2018 | 372 | 0.15 | Why? |
| Receptors, Urokinase Plasminogen Activator | 1 | 2018 | 252 | 0.15 | Why? |
| Pulmonary Emphysema | 1 | 2017 | 122 | 0.15 | Why? |
| Mucus | 1 | 2017 | 183 | 0.15 | Why? |
| Reperfusion Injury | 1 | 2017 | 178 | 0.15 | Why? |
| Endotoxemia | 1 | 2017 | 143 | 0.15 | Why? |
| Patient Care Planning | 1 | 2020 | 582 | 0.14 | Why? |
| NF-E2-Related Factor 2 | 1 | 2019 | 373 | 0.14 | Why? |
| Cell Movement | 1 | 2019 | 695 | 0.14 | Why? |
| Nerve Tissue Proteins | 1 | 2017 | 319 | 0.14 | Why? |
| Lectins, C-Type | 1 | 2017 | 405 | 0.14 | Why? |
| Humans | 42 | 2021 | 930598 | 0.14 | Why? |
| Protective Agents | 1 | 2017 | 250 | 0.14 | Why? |
| Coronavirus | 2 | 2020 | 18339 | 0.13 | Why? |
| Aged | 18 | 2021 | 215776 | 0.13 | Why? |
| Up-Regulation | 2 | 2019 | 2249 | 0.13 | Why? |
| Treatment Outcome | 5 | 2020 | 51732 | 0.13 | Why? |
| Gene Expression Regulation, Neoplastic | 2 | 2017 | 1014 | 0.13 | Why? |
| Trace Elements | 1 | 2017 | 284 | 0.13 | Why? |
| Heart Injuries | 1 | 2020 | 608 | 0.13 | Why? |
| Inhalation Exposure | 1 | 2018 | 405 | 0.13 | Why? |
| Respiratory Tract Infections | 3 | 2019 | 6817 | 0.13 | Why? |
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2017 | 511 | 0.13 | Why? |
| Pleural Effusion | 1 | 2019 | 680 | 0.13 | Why? |
| Middle Aged | 19 | 2021 | 270681 | 0.12 | Why? |
| Influenza A Virus, H7N9 Subtype | 1 | 2017 | 415 | 0.12 | Why? |
| Pseudomonas aeruginosa | 1 | 2018 | 652 | 0.12 | Why? |
| Hydrogen-Ion Concentration | 3 | 2018 | 993 | 0.12 | Why? |
| Survival Rate | 4 | 2020 | 9206 | 0.12 | Why? |
| Neoplasm Proteins | 1 | 2017 | 501 | 0.12 | Why? |
| Propensity Score | 1 | 2020 | 2690 | 0.12 | Why? |
| Water | 1 | 2017 | 765 | 0.11 | Why? |
| Anti-Bacterial Agents | 3 | 2019 | 10083 | 0.11 | Why? |
| Retrospective Studies | 8 | 2021 | 105322 | 0.11 | Why? |
| Risk Factors | 8 | 2021 | 71621 | 0.11 | Why? |
| Treatment Failure | 1 | 2017 | 2106 | 0.11 | Why? |
| Female | 20 | 2020 | 380317 | 0.10 | Why? |
| Dexamethasone | 2 | 2020 | 2055 | 0.10 | Why? |
| Orthomyxoviridae Infections | 1 | 2017 | 1001 | 0.10 | Why? |
| Kaplan-Meier Estimate | 1 | 2019 | 4260 | 0.10 | Why? |
| Adult | 13 | 2021 | 244371 | 0.10 | Why? |
| Autophagy | 1 | 2017 | 960 | 0.10 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2018 | 1115 | 0.10 | Why? |
| Uncertainty | 1 | 2021 | 1888 | 0.10 | Why? |
| Mice, Transgenic | 1 | 2017 | 2739 | 0.10 | Why? |
| Hypertension, Pulmonary | 1 | 2018 | 970 | 0.09 | Why? |
| Pneumonia, Viral | 7 | 2020 | 243684 | 0.09 | Why? |
| Positive-Pressure Respiration | 1 | 2017 | 1160 | 0.09 | Why? |
| Multiple Organ Failure | 1 | 2019 | 1724 | 0.09 | Why? |
| Severity of Illness Index | 5 | 2019 | 48226 | 0.09 | Why? |
| Biopsy | 1 | 2017 | 2811 | 0.09 | Why? |
| Membrane Potential, Mitochondrial | 2 | 2019 | 102 | 0.09 | Why? |
| Biomarkers, Tumor | 1 | 2017 | 1314 | 0.09 | Why? |
| Hospitalization | 6 | 2020 | 54280 | 0.09 | Why? |
| Fiber Optic Technology | 1 | 2008 | 71 | 0.09 | Why? |
| Sepsis | 3 | 2019 | 3517 | 0.09 | Why? |
| Temperature | 1 | 2017 | 2305 | 0.09 | Why? |
| Lung Injury | 1 | 2017 | 919 | 0.09 | Why? |
| Antineoplastic Agents | 3 | 2019 | 3550 | 0.08 | Why? |
| Spectrometry, Fluorescence | 1 | 2008 | 177 | 0.08 | Why? |
| Disease Progression | 4 | 2020 | 13580 | 0.08 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.08 | Why? |
| Mesenchymal Stem Cell Transplantation | 1 | 2019 | 1322 | 0.08 | Why? |
| Apoptosis | 4 | 2019 | 2335 | 0.08 | Why? |
| Antioxidants | 1 | 2017 | 1593 | 0.08 | Why? |
| Pulmonary Fibrosis | 1 | 2017 | 1068 | 0.08 | Why? |
| Respiratory Function Tests | 3 | 2018 | 1755 | 0.08 | Why? |
| Epithelial Cells | 1 | 2019 | 3508 | 0.08 | Why? |
| Cell Line | 2 | 2019 | 12040 | 0.08 | Why? |
| Gene Expression Regulation | 1 | 2019 | 4020 | 0.08 | Why? |
| Vital Capacity | 2 | 2018 | 399 | 0.08 | Why? |
| Disease Models, Animal | 3 | 2018 | 10998 | 0.08 | Why? |
| Home Care Services | 1 | 2017 | 1351 | 0.07 | Why? |
| Gastrointestinal Diseases | 1 | 2020 | 2580 | 0.07 | Why? |
| Software | 1 | 2017 | 2501 | 0.07 | Why? |
| Epitopes | 1 | 2017 | 4113 | 0.07 | Why? |
| Liver Diseases | 1 | 2020 | 2698 | 0.07 | Why? |
| Length of Stay | 2 | 2019 | 11042 | 0.07 | Why? |
| Smoking | 1 | 2018 | 3358 | 0.07 | Why? |
| Prospective Studies | 5 | 2021 | 43301 | 0.07 | Why? |
| Blood Gas Analysis | 1 | 2008 | 893 | 0.07 | Why? |
| Noninvasive Ventilation | 1 | 2017 | 2329 | 0.07 | Why? |
| Cough | 1 | 2017 | 4891 | 0.06 | Why? |
| Virus Shedding | 1 | 2020 | 5834 | 0.06 | Why? |
| Hypoxia | 1 | 2018 | 3626 | 0.06 | Why? |
| Mice, Inbred BALB C | 3 | 2019 | 5814 | 0.06 | Why? |
| Diagnosis, Differential | 1 | 2017 | 7220 | 0.06 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.06 | Why? |
| Multivariate Analysis | 3 | 2019 | 5440 | 0.06 | Why? |
| Venous Thromboembolism | 1 | 2021 | 4273 | 0.06 | Why? |
| Air Pollution | 2 | 2018 | 3504 | 0.06 | Why? |
| Follow-Up Studies | 1 | 2020 | 17020 | 0.06 | Why? |
| Drug Repositioning | 1 | 2020 | 5683 | 0.06 | Why? |
| Pandemics | 7 | 2020 | 389249 | 0.05 | Why? |
| Acute Kidney Injury | 1 | 2020 | 5762 | 0.05 | Why? |
| Capsules | 1 | 2020 | 140 | 0.05 | Why? |
| Oxygen | 2 | 2017 | 3715 | 0.05 | Why? |
| Adolescent | 3 | 2019 | 86841 | 0.05 | Why? |
| Fluorescent Dyes | 1 | 2003 | 536 | 0.05 | Why? |
| Aged, 80 and over | 6 | 2020 | 88759 | 0.05 | Why? |
| Young Adult | 3 | 2019 | 93724 | 0.05 | Why? |
| Air Pollutants | 1 | 2017 | 3110 | 0.05 | Why? |
| Cecum | 1 | 2019 | 63 | 0.05 | Why? |
| Ligation | 1 | 2019 | 84 | 0.05 | Why? |
| Contact Tracing | 1 | 2019 | 8448 | 0.05 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.05 | Why? |
| Bronchoalveolar Lavage Fluid | 2 | 2019 | 2309 | 0.05 | Why? |
| Receptor-Interacting Protein Serine-Threonine Kinase 2 | 1 | 2017 | 19 | 0.05 | Why? |
| Folic Acid Antagonists | 1 | 2018 | 40 | 0.05 | Why? |
| Epidemics | 1 | 2019 | 6407 | 0.05 | Why? |
| beta-Defensins | 1 | 2018 | 38 | 0.04 | Why? |
| Antibodies, Monoclonal | 1 | 2017 | 8041 | 0.04 | Why? |
| Corn Oil | 1 | 2017 | 1 | 0.04 | Why? |
| Gene Knockdown Techniques | 1 | 2019 | 347 | 0.04 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2017 | 10649 | 0.04 | Why? |
| Cell Cycle | 1 | 2019 | 329 | 0.04 | Why? |
| Xenograft Model Antitumor Assays | 1 | 2018 | 274 | 0.04 | Why? |
| Albuterol | 1 | 2018 | 105 | 0.04 | Why? |
| Tumor Cells, Cultured | 1 | 2017 | 254 | 0.04 | Why? |
| Oxidative Stress | 2 | 2019 | 2050 | 0.04 | Why? |
| Host-Pathogen Interactions | 1 | 2017 | 11041 | 0.04 | Why? |
| Caspase 3 | 1 | 2017 | 218 | 0.04 | Why? |
| Gene Expression Profiling | 2 | 2019 | 3788 | 0.04 | Why? |
| Monitoring, Physiologic | 1 | 2008 | 1956 | 0.04 | Why? |
| Molecular Conformation | 1 | 2017 | 374 | 0.04 | Why? |
| Poly(ADP-ribose) Polymerases | 1 | 2017 | 91 | 0.04 | Why? |
| Tomography, X-Ray Computed | 3 | 2017 | 25144 | 0.04 | Why? |
| Odds Ratio | 2 | 2019 | 5861 | 0.04 | Why? |
| Pleural Diseases | 1 | 2017 | 68 | 0.04 | Why? |
| Cells, Cultured | 2 | 2017 | 5835 | 0.04 | Why? |
| Confidence Intervals | 1 | 2018 | 744 | 0.04 | Why? |
| Incidence | 1 | 2017 | 25622 | 0.04 | Why? |
| Madin Darby Canine Kidney Cells | 1 | 2017 | 640 | 0.04 | Why? |
| Intention to Treat Analysis | 1 | 2017 | 673 | 0.04 | Why? |
| Immunoglobulins | 1 | 2020 | 811 | 0.04 | Why? |
| Biomarkers | 4 | 2018 | 23361 | 0.03 | Why? |
| Infant | 1 | 2017 | 30274 | 0.03 | Why? |
| Respiration, Artificial | 1 | 2019 | 22116 | 0.03 | Why? |
| Chi-Square Distribution | 1 | 2017 | 961 | 0.03 | Why? |
| Mice, Knockout | 1 | 2019 | 1815 | 0.03 | Why? |
| Spirometry | 1 | 2017 | 524 | 0.03 | Why? |
| Probability | 1 | 2017 | 923 | 0.03 | Why? |
| Geography | 1 | 2019 | 1801 | 0.03 | Why? |
| Public Health | 1 | 2019 | 16359 | 0.03 | Why? |
| Child, Preschool | 1 | 2017 | 36283 | 0.03 | Why? |
| Glucose | 1 | 2017 | 573 | 0.03 | Why? |
| Influenza, Human | 1 | 2017 | 10779 | 0.03 | Why? |
| RNA, Small Interfering | 1 | 2017 | 817 | 0.03 | Why? |
| Bronchodilator Agents | 1 | 2018 | 444 | 0.03 | Why? |
| Logistic Models | 2 | 2018 | 9089 | 0.03 | Why? |
| Gastrointestinal Tract | 1 | 2020 | 1113 | 0.03 | Why? |
| Cell Survival | 1 | 2018 | 1581 | 0.03 | Why? |
| Equipment Design | 2 | 2017 | 3095 | 0.03 | Why? |
| Indoles | 1 | 2020 | 1243 | 0.03 | Why? |
| Asia | 1 | 2019 | 2399 | 0.03 | Why? |
| Administration, Inhalation | 1 | 2018 | 1647 | 0.03 | Why? |
| NF-kappa B | 1 | 2019 | 1301 | 0.03 | Why? |
| Prognosis | 3 | 2020 | 32490 | 0.03 | Why? |
| Time Factors | 3 | 2020 | 31397 | 0.03 | Why? |
| Carbon Dioxide | 1 | 2017 | 917 | 0.03 | Why? |
| Immunohistochemistry | 1 | 2017 | 2275 | 0.03 | Why? |
| Dogs | 1 | 2017 | 2529 | 0.03 | Why? |
| Infection Control | 1 | 2019 | 23131 | 0.02 | Why? |
| Methylprednisolone | 1 | 2020 | 2107 | 0.02 | Why? |
| Ruthenium | 1 | 2008 | 9 | 0.02 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2019 | 2483 | 0.02 | Why? |
| Dose-Response Relationship, Drug | 1 | 2018 | 3776 | 0.02 | Why? |
| Optical Fibers | 1 | 2008 | 35 | 0.02 | Why? |
| Transducers | 1 | 2008 | 65 | 0.02 | Why? |
| Real-Time Polymerase Chain Reaction | 2 | 2017 | 11367 | 0.02 | Why? |
| Interferons | 1 | 2020 | 2885 | 0.02 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
| Genomics | 1 | 2019 | 3118 | 0.02 | Why? |
| Membrane Proteins | 1 | 2017 | 1733 | 0.02 | Why? |
| Feces | 1 | 2020 | 4235 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2019 | 6543 | 0.02 | Why? |
| Recovery of Function | 1 | 2017 | 2461 | 0.02 | Why? |
| Endothelial Cells | 1 | 2017 | 2048 | 0.02 | Why? |
| Liver | 1 | 2020 | 4007 | 0.02 | Why? |
| Acute Disease | 1 | 2018 | 6029 | 0.02 | Why? |
| ROC Curve | 1 | 2017 | 6024 | 0.02 | Why? |
| Risk | 1 | 2017 | 5288 | 0.02 | Why? |
| Risk Assessment | 2 | 2021 | 25439 | 0.02 | Why? |
| Ventilators, Mechanical | 1 | 2017 | 2193 | 0.02 | Why? |
| RNA, Messenger | 1 | 2019 | 5131 | 0.02 | Why? |
| Rabbits | 1 | 2008 | 1171 | 0.02 | Why? |
| HEK293 Cells | 1 | 2017 | 8394 | 0.02 | Why? |
| Computational Biology | 1 | 2018 | 4514 | 0.02 | Why? |
| Consensus | 1 | 2017 | 6345 | 0.01 | Why? |
| Virus Diseases | 1 | 2019 | 3779 | 0.01 | Why? |
| Influenza Vaccines | 1 | 2017 | 2941 | 0.01 | Why? |
| Case-Control Studies | 1 | 2018 | 17671 | 0.01 | Why? |
| Registries | 1 | 2019 | 12327 | 0.01 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.01 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.01 | Why? |
| Quality of Life | 1 | 2017 | 9820 | 0.01 | Why? |
| Prevalence | 1 | 2018 | 25773 | 0.01 | Why? |
| Global Health | 1 | 2019 | 13911 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2008 | 11304 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2018 | 53120 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2017 | 43792 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2008 | 22971 | 0.01 | Why? |